UBS Tx-Optimized Idxd Port AM Intl Eq (S:0P0001JH0H)
16.73
+0.37
(+2.25%)
USD |
Sep 30 2025
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of December 26, 2025.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| ASML Holding NV | 2.14% | 1071.89 | 0.60% |
| SAP SE | 1.52% | 245.80 | 0.08% |
| National Australia Bank Ltd. | 1.52% | 14.24 | -0.56% |
| Novartis AG | 1.43% | 138.42 | -0.33% |
| HSBC Holdings Plc | 1.38% | 79.72 | 0.18% |
| AstraZeneca PLC | 1.35% | 92.62 | 0.18% |
| Roche Holding AG | 1.33% | 52.32 | -0.39% |
| Nestlé SA | 1.25% | 98.41 | -0.04% |
| Mitsubishi UFJ Financial Group, Inc. | 1.25% | 15.86 | -0.53% |
| Siemens AG | 1.20% | 140.32 | -0.18% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Attributes | |
| Socially Responsible Fund | -- |